Marcum Wealth LLC raised its holdings in MetLife, Inc. (NYSE:MET – Free Report) by 13.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 4,295 shares of the financial services provider’s stock after buying an additional 510 shares during the period. Marcum Wealth LLC’s holdings in MetLife were worth $352,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. MeadowBrook Investment Advisors LLC grew its stake in MetLife by 244.4% in the third quarter. MeadowBrook Investment Advisors LLC now owns 310 shares of the financial services provider’s stock valued at $26,000 after purchasing an additional 220 shares in the last quarter. Carmichael Hill & Associates Inc. grew its stake in shares of MetLife by 131.9% in the third quarter. Carmichael Hill & Associates Inc. now owns 327 shares of the financial services provider’s stock valued at $27,000 after buying an additional 186 shares in the last quarter. Wolff Wiese Magana LLC increased its holdings in MetLife by 374.3% during the third quarter. Wolff Wiese Magana LLC now owns 351 shares of the financial services provider’s stock worth $29,000 after buying an additional 277 shares during the last quarter. Peterson Financial Group Inc. bought a new stake in MetLife during the third quarter worth $30,000. Finally, Fortitude Family Office LLC lifted its stake in MetLife by 177.3% in the third quarter. Fortitude Family Office LLC now owns 416 shares of the financial services provider’s stock valued at $34,000 after acquiring an additional 266 shares during the last quarter. 94.99% of the stock is currently owned by institutional investors and hedge funds.
MetLife Price Performance
Shares of MetLife stock opened at $83.85 on Wednesday. MetLife, Inc. has a twelve month low of $64.61 and a twelve month high of $89.05. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.51. The company has a 50-day simple moving average of $83.16 and a two-hundred day simple moving average of $79.20. The stock has a market capitalization of $58.06 billion, a price-to-earnings ratio of 16.91, a price-to-earnings-growth ratio of 0.76 and a beta of 1.07.
MetLife Dividend Announcement
Analyst Upgrades and Downgrades
MET has been the subject of a number of recent analyst reports. Wells Fargo & Company cut their price target on shares of MetLife from $93.00 to $92.00 and set an “overweight” rating for the company in a research note on Tuesday. Jefferies Financial Group increased their price target on shares of MetLife from $89.00 to $95.00 and gave the company a “buy” rating in a research note on Friday, September 27th. JPMorgan Chase & Co. increased their price target on shares of MetLife from $86.00 to $88.00 and gave the company an “overweight” rating in a research note on Tuesday, January 7th. Piper Sandler increased their price target on shares of MetLife from $85.00 to $92.00 and gave the company an “overweight” rating in a research note on Wednesday, October 2nd. Finally, Barclays increased their price target on shares of MetLife from $90.00 to $96.00 and gave the company an “overweight” rating in a research note on Monday, January 6th. One research analyst has rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. Based on data from MarketBeat.com, MetLife currently has a consensus rating of “Moderate Buy” and an average price target of $89.92.
Read Our Latest Research Report on MetLife
MetLife Company Profile
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Read More
- Five stocks we like better than MetLife
- How Can Investors Benefit From After-Hours Trading
- The Fed Is More Likely to Hike Than Cut Rates in 2025
- Short Selling – The Pros and Cons
- Investors Navigate Uncertainty by Seeking Refuge in Gold and Oil
- Consumer Staples Stocks, Explained
- Archer Aviation Shares Slide, Now Bargain Priced for 2025
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.